CAMP4 Therapeutics Corporation (CAMP) — Analyst outlook / Analyst consensus target is. Based on 24 analyst ratings, the consensus is bullish — 16 Buy, 7 Hold, 1 Sell.
The consensus price target is $11.40 (low: $5.00, high: $18.00), representing an upside of 152.2% from the current price $4.52.
Analysts estimate Earnings Per Share (EPS) of $-8.33 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-2.52 vs est $-8.33 (beat +69.7%). 2025: actual $-2.66 vs est $-2.12 (missed -25.2%). Analyst accuracy: 0%.
CAMP Stock — 12-Month Price Forecast
$11.40
▲ +152.21% Upside
Average Price Target
Based on 24 Wall Street analysts offering 12-month price targets for CAMP4 Therapeutics Corporation, the average price target is $11.40, with a high forecast of $18.00, and a low forecast of $5.00.
The average price target represents a +152.21% change from the last price of $4.52.
Highest Price Target
$18.00
Average Price Target
$11.40
Lowest Price Target
$5.00
CAMP Analyst Ratings
Buy
Based on 24 analysts giving stock ratings to CAMP4 Therapeutics Corporation in the past 3 months
EPS Estimates — CAMP
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$2.52
vs Est –$8.33
▲ 230.6% off
2025
Actual –$2.66
vs Est –$2.12
▼ 20.1% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — CAMP
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.186B
vs Est $0.001B
▲ 99.6% off
2025
Actual $0.001B
vs Est $0.004B
▼ 445.1% off
Revenue Trend
Revenue has declined over the period shown. Analysts expect stable revenue going forward.
